International Journal of Fundamental & Applied SciencesISSN 2278-140420176431http://bma.org.in/ijfas.aspx@2017 BioMedAsia All right reserved Mapping the Resistance Potential of Influenza?s H + Channel Using an Anti-Viral BlockerInt. J. Fund. Appl. Sci. Vol.6, No. 4 (2017) 31-33Manuscript received 21st Nov, 2017, revised 12th Dec, 2017, accepted 28th Dec, 2017Short CommunicationMidhun ManoharDepartment of Biotechnology, BMS College of Engineering, Bangalore, India .Nihal KulkarniDepartment of Biotechnology, BMS College of Engineering, Bangalore, India .Pradeep SDepartment of Biotechnology, BMS College of Engineering, Bangalore, India .One of the biggest problems faced by biotechnologists and pharmacologists all over the world is the difficulty in predicting the strains of viral diseases that are coming into circulation. The problem becomes much worse when it becomes difficult to predict the virus?s resistance pattern. Influenza A virus has many factors that play a role in its infection cycle. Here, we are trying to study how the virus exhibits resistance against an anti-viral blocker. The blocker that is used in this case is amino-adamantane antiviral inhibitor (adamantine).Influenza A virus, Influenza M2 protein, adamantineConflicts of interestThe author?s declares none.